Prodotti della ricerca

 

UNICA IRIS Institutional Research Information System

IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Cagliari dal mese di luglio 2015.

Mostra risultati da 1 a 20 di 39
successivo >
TitoloData di pubblicazioneAutore(i)RivistaEditore
Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence2017Cadoni, Cristina; Pisanu, Augusta; Simola, Nicola; Frau, Lucia; Porceddu, PIER FRANCESCA; Corongi...u, Silvia; Dessi', Christian; Sil, Annesha; Plumitallo, Antonio; Wardas, Jadwiga; DI CHIARA, GaetanoNEUROPHARMACOLOGY
Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain2016Frau, Lucia; Simola, Nicola; Porceddu, PIER FRANCESCA; Morelli, MicaelaNEUROTOXICOLOGY
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease2016Baranyi, M; Porceddu, Pf; Goloncser, F; Kulcsar, S; Otrokocsi, L; Kittel, A; Pinna, A; Frau, L; H...uleatt, Pb.; Khoo, Ml; Chai, Cll.; Dunkel, P; Matyus, P; Morelli, M; Sperlagh, BMOLECULAR NEURODEGENERATION
Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent2016Frau, Lucia; Costa, Giulia; Porceddu, Pier Francesca; Khairnar, Amit; Castelli, Maria Paola; Enna...s, Maria Grazia; Madeddu, Camilla; Wardas, Jadwiga; Morelli, MicaelaJOURNAL OF NEUROCHEMISTRY
Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: Implications for the study of the affective properties of drugs of abuse2014SIMOLA N; FRAU L; PLUMITALLO A; MORELLI MINTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists2014SIMOLA N; PINNA A; FRAU L; MORELLI MSpringer
Antagonism of Adenosine A1 or A2A Receptors Amplifies the Effects of 3,4-Methylendioxymethamphetamine (MDMA) on Glial Activation in the Mouse Brain: Relevance to Caffeine-MDMA Interactions2014KHAIRNAR A; FRAU L; PLUMITALLO A; MORELLI M; SIMOLA NJOURNAL OF CAFFEINE RESEARCH
Contribution of Caffeine to the Psychostimulant, Neuroinflammatory and Neurotoxic Effects of Amphetamine-Related Drugs2013FRAU L; SIMOLA N; MORELLI MJOURNAL OF CAFFEINE RESEARCH
Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease2013PINNA A; SIMOLA N; FRAU L; MORELLI MSpringer Science
MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA pretreated mice2013COSTA G; FRAU L; WARDAS J; PINNA A; PLUMITALLO A; MORELLI MMOVEMENT DISORDERS
Role of movement in long-term basal ganglia changes: implications for abnormal motor responses2013SIMOLA N; MORELLI M; FRAZZITTA G; FRAU LFRONTIERS IN COMPUTATIONAL NEUROSCIENCE
Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons2013FRAU L; MORELLI M; SIMOLA NEXPERIMENTAL NEUROLOGY
Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility2013FRAU L; SIMOLA N; PLUMITALLO A; MORELLI MJOURNAL OF NEUROCHEMISTRY
Alteration in the progression of dopamine neuron degeneration: May caffeine offer new perspective?2012MORELLI M; FRAU L; SIMOLA NEXPERIMENTAL NEUROLOGY
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice2012Baiguera, C; Alghisi, M; Pinna, A; Bellucci, A; DE LUCA, Ma; Frau, L; Morelli, M; Ingrassia, R; B...enarese, M; Porrini, V; Pellitteri, M; Bertini, G; Fabene, Pf; Sigala, S; Spillantini, Mg; Liou, Hc; Spano, Pf; Pizzi, MBRAIN
Caffeine potentiation of 3,4-methylenedioxymethamphetamine (MDMA) toxicity: role of age2011Frau L; Khairnar A; Fenu S; Morelli M
Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease.2011FRAU L; BORSINI F; WARDAS J; KHAIRNAR AS; SCHINTU N; MORELLI M.SYNAPSE
A442 PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests neurodegeneration in a progressive Parkinson´s disease model 2011CARTA AR; PISANU A; FRAU L; SPIGA S; CARBONI EInternational brain resesearch organization
Effect of adenosine A1 and A2A antagonists on 3,4 methylenedioxymethamphetamine (MDMA)-induced neuroinflammation and dopamine neuron toxicity in mouse brain2011Khairnar A; Frau L; Fenu S; Plumitallo A; Morelli M
Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model. 2011Carta AR; Frau L; Pisanu A; Wardas J; Spiga S; Carboni E.NEUROSCIENCE
   
credits unica.it | accessibilità Università degli Studi di Cagliari
C.F.: 80019600925 - P.I.: 00443370929
note legali | privacy

Nascondi la toolbar